## HIG: The Hartford Insurance Group, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.41 indicates fundamental undervaluation. Quality metrics strong (ROE 20%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-3.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($134.68)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Oak Thistle LLC Lowers Stake in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251221T060814 | Somewhat-Bullish | Relevance: 100%
- Oak Thistle LLC significantly reduced its holdings in The Hartford Insurance Group (NYSE:HIG) by 89.9% in Q3, selling 30,932 shares and retaining 3,477 shares. Despite this reduction, institutional ownership remains high at 93.42%, with other firms like Norges Bank, Franklin Resources, and Woodline Partners substantially increasing their stakes. The Hartford recently beat Q3 EPS estimates, raised its quarterly dividend, and holds a "Moderate Buy" consensus rating from analysts.

**2. Osaic Holdings Inc. Has $10.50 Million Stock Holdings in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251221T103759 | Bullish | Relevance: 99%
- Osaic Holdings Inc. significantly increased its stake in The Hartford Insurance Group, Inc. by 217% in Q2, acquiring 83,904 shares valued at $10.495 million. This comes as The Hartford reported strong earnings, beating estimates by $0.76 per share, and raised its quarterly dividend to $0.60. Analysts maintain a "Moderate Buy" consensus rating with a target price of $144.60, with some firms setting targets as high as $155.00.

**3. Hartford Financial Services Group stock hits all-time high at 139.93 USD**
- Source: Investing.com Nigeria | 20251223T030813 | Bullish | Relevance: 99%
- Hartford Financial Services Group (HIG) stock has reached an all-time high of $139.93, marking a 29.13% increase over the past year. The company boasts a market capitalization of $38.95 billion, a P/E ratio of 11.4, and has maintained dividend payments for 30 consecutive years, while also surpassing recent Q3 2025 earnings expectations. Analyst opinions are mixed, with Mizuho and UBS issuing positive ratings, while Goldman Sachs lowered its price target due to concerns over loss ratios.

**4. Is SiriusPointâ€™s Index Inclusion And Analyst Optimism Altering The Investment Case For SPNT?**
- Source: Simply Wall Street | 20251223T030916 | Neutral | Relevance: 64%
- SiriusPoint Ltd. (NYSE: SPNT) was recently added to the S&P Insurance Select Industry Index, coinciding with strong analyst enthusiasm and positive earnings estimate trends. This inclusion could increase institutional awareness and trading interest, though the core investment case still hinges on disciplined underwriting and MGA partnerships. The company reaffirmed its 2025 net interest income guidance, emphasizing the role of fixed income returns in its profitability.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Piper Sandler | $161 | $152 | +6% |
| 2025-12-16 | Mizuho | $160 | $0 | 0% |
| 2025-12-08 | UBS | $155 | $151 | +3% |
| 2025-11-25 | Argus Research | $155 | $143 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Piper Sandler | main | Overweight |
| 2025-12-16 | Mizuho | init | Outperform |
| 2025-12-08 | UBS | main | Buy |
| 2025-11-25 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.96M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-0.8%)
- Blackrock Inc.: 10.9% (-4.4%)
- State Street Corpora: 5.8% (+0.3%)
- FMR, LLC: 4.9% (+13.2%)
- Price (T.Rowe) Assoc: 3.1% (-11.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.41 suggests fair value with growth premium. Quality metrics strong (ROE 20%). Balance sheet: strong liquidity (17.8x), $1.8B free cash flow. Analyst sentiment positive (3 raises, avg +6%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $38.8B |
| Beta | 0.63 |
| 52W Range | $104.93 - $140.48 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.41 |
| Forward P/E | 10.5 |
| Current P/E | 11.1 |
| YoY Growth | 5.4% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.0% to 1.7% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.3pp (needs >4.0% for momentum thesis). MRS_5 (-1.5%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.69% (CS: 73) | Neutral |
| RSI_14 | 65.0 | Neutral |
| MACD Histogram | 0.44 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.059x | Above |
| vs SMA200 | 1.092x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $139.06
- **Stop Loss:** $134.68 (3.1% risk)
- **Target:** $147.82 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 205
- **Position Value:** $28,507.30
- **Portfolio %:** 28.51%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-29 (Est: $3.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.21 | $3.78 | +17.6% |
| 2025Q2 | $2.83 | $3.41 | +20.4% |
| 2025Q1 | $2.15 | $2.20 | +2.5% |
| 2024Q4 | $2.64 | $2.94 | +11.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*